262 related articles for article (PubMed ID: 33250837)
21. Amyloid and Tau as cerebrospinal fluid biomarkers in anti-N-Methyl-D-aspartate receptor encephalitis.
Hao Q; Gong Z; Song Y; Wang Y; Meng W; Wu W; Li Y; Zhang Y
Neurol Sci; 2024 Jul; 45(7):3399-3410. PubMed ID: 38280087
[TBL] [Abstract][Full Text] [Related]
22. Elevated Plasma Homocysteine Levels in Anti-N-methyl-D-aspartate Receptor Encephalitis.
Liu L; Liang J; Liu Q; Luo C; Liu J; Fan R; Chen Z; Chen Y; Peng F; Jiang Y
Front Neurol; 2019; 10():464. PubMed ID: 31130913
[No Abstract] [Full Text] [Related]
23. Cerebrospinal fluid pentraxin 3 and CD40 ligand in anti-N-menthyl-d-aspartate receptor encephalitis.
Liu B; Ai P; Zheng D; Jiang Y; Liu X; Pan S; Wang H
J Neuroimmunol; 2018 Feb; 315():40-44. PubMed ID: 29306404
[TBL] [Abstract][Full Text] [Related]
24. Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response.
Leypoldt F; Höftberger R; Titulaer MJ; Armangue T; Gresa-Arribas N; Jahn H; Rostásy K; Schlumberger W; Meyer T; Wandinger KP; Rosenfeld MR; Graus F; Dalmau J
JAMA Neurol; 2015 Feb; 72(2):180-6. PubMed ID: 25436993
[TBL] [Abstract][Full Text] [Related]
25. The relevance of NMDA receptor antibody-specific index for diagnosis and prognosis in patients with anti-NMDA receptor encephalitis.
Hümmert MW; Jendretzky KF; Fricke K; Gingele M; Ratuszny D; Möhn N; Trebst C; Skripuletz T; Gingele S; Sühs KW
Sci Rep; 2023 Aug; 13(1):12696. PubMed ID: 37542085
[TBL] [Abstract][Full Text] [Related]
26. Distinct intrathecal interleukin-17/interleukin-6 activation in anti-N-methyl-d-aspartate receptor encephalitis.
Byun JI; Lee ST; Moon J; Jung KH; Sunwoo JS; Lim JA; Kim TJ; Shin YW; Lee KJ; Jun JS; Lee HS; Lee WJ; Kim YS; Kim S; Jeon D; Park KI; Jung KY; Kim M; Chu K; Lee SK
J Neuroimmunol; 2016 Aug; 297():141-7. PubMed ID: 27397087
[TBL] [Abstract][Full Text] [Related]
27. Factors influencing prognosis and relapse in patients with anti-N-methyl-D-aspartate receptor encephalitis.
Wu Q; Xie Q; Liu L; Meng C; Wang J
Mult Scler Relat Disord; 2023 Jun; 74():104697. PubMed ID: 37031550
[TBL] [Abstract][Full Text] [Related]
28. Th17 cells were recruited and accumulated in the cerebrospinal fluid and correlated with the poor prognosis of anti-NMDAR encephalitis.
Zeng C; Chen L; Chen B; Cai Y; Li P; Yan L; Zeng D
Acta Biochim Biophys Sin (Shanghai); 2018 Dec; 50(12):1266-1273. PubMed ID: 30418472
[TBL] [Abstract][Full Text] [Related]
29. Clinical Features, Treatment, and Outcomes Among Chinese Children With Anti-methyl-D-aspartate Receptor (Anti-NMDAR) Encephalitis.
Zhang M; Li W; Zhou S; Zhou Y; Yang H; Yu L; Wang J; Wang Y; Zhang L
Front Neurol; 2019; 10():596. PubMed ID: 31244759
[No Abstract] [Full Text] [Related]
30. Elevated blood and cerebrospinal fluid biomarkers of microglial activation and blood‒brain barrier disruption in anti-NMDA receptor encephalitis.
Chang H; Ma J; Feng K; Feng N; Wang X; Sun J; Guo T; Wei Y; Xu Y; Wang H; Yin L; Zhang X
J Neuroinflammation; 2023 Jul; 20(1):172. PubMed ID: 37481571
[TBL] [Abstract][Full Text] [Related]
31. Serum uric acid and anti-N-methyl-d-aspartate receptor encephalitis.
Shu Y; Wang Y; Lu T; Li R; Sun X; Li J; Chang Y; Hu X; Lu Z; Qiu W
Neurochem Int; 2017 Sep; 108():34-39. PubMed ID: 28192149
[TBL] [Abstract][Full Text] [Related]
32. Protein A immunoadsorption for the treatment of refractory anti-N-methyl-d-aspartate receptor encephalitis: A single-center prospective study.
Zhang B; Yu D; Zhu Q; Ruan H; Yu B; Cui C; Yang Y; Qiu W
J Neurol Sci; 2021 Sep; 428():117568. PubMed ID: 34247015
[TBL] [Abstract][Full Text] [Related]
33. Association of serum Gasdermin D with anti-N-methyl-D-aspartate receptor encephalitis.
Ma X; Chen C; Lu Y; Fang L; Cao B; Hu X; Qiu W; Shu Y
J Neurochem; 2021 Dec; 159(5):923-930. PubMed ID: 34418095
[TBL] [Abstract][Full Text] [Related]
34. Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: A systematic review and meta-analysis.
Ma Y; Wang J; Guo S; Meng Z; Ren Y; Xie Y; Wang M
Front Immunol; 2022; 13():1064007. PubMed ID: 36761173
[TBL] [Abstract][Full Text] [Related]
35. Elevated cerebrospinal fluid YKL-40 levels in patients with anti-gamma-aminobutyric- acid-B receptor encephalitis.
Li J; Wang Y; Xia R; Zhao X; Li L; Wang S
J Neuroimmunol; 2023 Aug; 381():578119. PubMed ID: 37301084
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid cyto-/chemokine profile during acute herpes simplex virus induced anti-N-methyl-d-aspartate receptor encephalitis and in chronic neurological sequelae.
Kothur K; Gill D; Wong M; Mohammad SS; Bandodkar S; Arbunckle S; Wienholt L; Dale RC
Dev Med Child Neurol; 2017 Aug; 59(8):806-814. PubMed ID: 28439892
[TBL] [Abstract][Full Text] [Related]
37. Serum cystatin C and anti-N-methyl-D-aspartate receptor encephalitis.
Shu Y; Chang Y; Wu H; Li J; Cao B; Sun X; Wang J; Peng L; Hu X; Yu X; Qiu W
Acta Neurol Scand; 2018 May; 137(5):515-522. PubMed ID: 29315460
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis.
Ciano-Petersen NL; Robert M; Muñiz-Castrillo S; Wucher V; Klich A; Vogrig A; Villagrán García M; Farina A; Goncalves D; Picard G; Rogemond V; Joubert B; Oliver-Martos B; Serrano-Castro PJ; Maucort-Boulch D; Honnorat J
Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37147137
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.
Malter MP; Elger CE; Surges R
Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046
[TBL] [Abstract][Full Text] [Related]
40. Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis.
Liu B; Xie Z; Liu G; Gu Y; Pan S; Wang H
Clin Chim Acta; 2018 May; 480():79-83. PubMed ID: 29329729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
